Cargando…

Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)

Detalles Bibliográficos
Autores principales:	Luo, Jian-Quan, Shu, Yan, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545849/ https://www.ncbi.nlm.nih.gov/pubmed/37795358 http://dx.doi.org/10.3389/fendo.2023.1287807

Ejemplares similares

Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment
por: Jia, Liyang, et al.
Publicado: (2023)

Pharmacomicrobiomics in Western Medicine and Traditional Chinese Medicine in Type 2 Diabetes
por: Chu, Natural, et al.
Publicado: (2022)

Editorial of Special Issue “Pharmacomicrobiomics in Non-Communicable Disease”
por: Amedei, Amedeo
Publicado: (2022)

Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment
por: Chen, Hui-Qing, et al.
Publicado: (2022)

Editorial: Ocular complications associated with diabetes mellitus
por: Zhang, Xinyuan, et al.
Publicado: (2023)

Visceral Adiposity Index in Type 2 Diabetes Mellitus (DM) and Its Correlation With Microvascular Complications
por: Hulkoti, Vidyashree, et al.
Publicado: (2022)

Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation
por: Stedman, Mike, et al.
Publicado: (2020)

High Normal Urinary Albumin–Creatinine Ratio Is Associated With Hypertension, Type 2 Diabetes Mellitus, HTN With T2DM, Dyslipidemia, and Cardiovascular Diseases in the Chinese Population: A Report From the REACTION Study
por: Wang, Jie, et al.
Publicado: (2022)

Association of epilepsy, anti-epileptic drugs (AEDs), and type 2 diabetes mellitus (T2DM): a population-based cohort retrospective study, impact of AEDs on T2DM-related molecular pathway, and via peroxisome proliferator-activated receptor γ transactivation
por: Tien, Ni, et al.
Publicado: (2023)

Prolactin is associated with bone mineral density in subjects with type 2 diabetes mellitus
por: Chen, Jia, et al.
Publicado: (2022)

Combined diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 1 diabetes mellitus induced by immune checkpoint inhibitors: Underrecognized and underreported emergency in ICIs-DM
por: Zhang, Wenjing, et al.
Publicado: (2023)

Editorial: The link between obesity, type 2 diabetes, and mitochondria
por: Luo, Moulun, et al.
Publicado: (2023)

Association of PON2 Gene Polymorphisms (Ser311Cys and Ala148Gly) With the Risk of Developing Type 2 Diabetes Mellitus in the Chinese Population
por: Ren, Huan, et al.
Publicado: (2018)

Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients
por: Han, Meifang, et al.
Publicado: (2021)

Role of Sphingosine Kinase in Type 2 Diabetes Mellitus
por: Qi, Yanfei, et al.
Publicado: (2021)

Anaemia among primary care patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD): a multicentred cross-sectional study
por: Idris, Iliza, et al.
Publicado: (2018)

Pharmacomicrobiomics of Antidepressants in Depression: A Systematic Review
por: Brown, Lisa C., et al.
Publicado: (2023)

Editorial: Novel Biomarkers for Type 2 Diabetes
por: Ahluwalia, Tarunveer S., et al.
Publicado: (2019)

Progression to type 2 diabetes mellitus after gestational diabetes mellitus diagnosed by IADPSG criteria: Systematic review and meta-analysis
por: Juan, Juan, et al.
Publicado: (2022)

Decreased Urine N6-methyladenosine level is closely associated with the presence of diabetic nephropathy in type 2 diabetes mellitus
por: Wan, Shu-jun, et al.
Publicado: (2022)

Gut microbiota influence in type 2 diabetes mellitus (T2DM)
por: Cunningham, A. L., et al.
Publicado: (2021)

Altered dynamic functional architecture in type 2 diabetes mellitus
por: Li, Yifan, et al.
Publicado: (2023)

Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Li, Mengni, et al.
Publicado: (2021)

Gut microbiota: A new target for T2DM prevention and treatment
por: Liu, Lulu, et al.
Publicado: (2022)

Pharmacological approaches to the prevention of type 2 diabetes mellitus
por: Majety, Priyanka, et al.
Publicado: (2023)

Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus
por: Ramírez-Alarcón, Karina, et al.
Publicado: (2021)

Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus
por: Guo, Xinyang, et al.
Publicado: (2023)

The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus
por: Dong, Yuyan, et al.
Publicado: (2022)

Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
por: Wu, Jiaqiang, et al.
Publicado: (2023)

Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
por: Yang, Jiaying, et al.
Publicado: (2023)

Pharmacomicrobiomics of Classical Immunosuppressant Drugs: A Systematic Review
por: Manes, Annalaura, et al.
Publicado: (2023)

Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
por: Panebianco, Concetta, et al.
Publicado: (2018)

Pharmacomicrobiomics: a novel route towards personalized medicine?
por: Doestzada, Marwah, et al.
Publicado: (2018)

Bringing pharmacomicrobiomics to the clinic through well‐designed studies
por: Steiner, Heidi E., et al.
Publicado: (2022)

Association Between Lipoprotein (A) and Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis
por: Ren, Xiaoyan, et al.
Publicado: (2021)

Corrigendum: The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus
por: Dong, Yuyan, et al.
Publicado: (2022)

Genomic DNA Methylation in Diabetic Chronic Complications in Patients With Type 2 Diabetes Mellitus
por: Wang, Xixi, et al.
Publicado: (2022)

Excellent Outcome of Protocol-Based Treatment of Motivated Type 2 Diabetes Mellitus (T2DM) Patients: A Real World Follow-Up for 11 Years
por: Chatterjee, Sudip, et al.
Publicado: (2020)

Assessment of left ventricular function in patients with type 2 diabetes mellitus by non-invasive myocardial work
por: Cao, Wenjia, et al.
Publicado: (2023)

Nerve conduction velocity is independently associated with bone mineral density in type 2 diabetes mellitus
por: Chen, Xiao-jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hndh7q4ro0emad9um3t88rd7v1